SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3036onty.... post-asco abstract release selling, 15%. Please see the thread if inscaram(o)uche-5/16/2013
3035ttnp on crl...big surprise (at least to me)fred hayes-5/1/2013
3034cprx down 18.82% on no news I can find (I am a newby) and considerably lower volpaul ta-4/30/2013
3033Tuck: IMHO, the DYAX plunge may be overdone, given the potential of their phage BulbaMan-4/26/2013
3032Dyax (DYAX) off about 30% as earnings disappoint. I don't know enough abouttuck-4/26/2013
3031EXAS -27% on tepid (although technically successful) DeeP-C results: siliconinvDewDiligence_on_SI-4/18/2013
3030Adam Feuerstein is high on SRPT, thinks approval is a done deal. (Many people ltom pope-4/17/2013
3029My once a year post. Another year older, another year...... forget what I was gokenhott14/17/2013
3028SRPT -15% at day's low, closed -13% Tue Apr 16, 2013 9:32am EDT (Reuters) -tnsaf-4/17/2013
3027Rigel (RIGL) off 33% on P3 efficacy failure in RA. There are a couple of more stuck-4/5/2013
3026PolyMedix (PYMXD), having just done a reverse split, files for chapter 7, splutttuck-4/1/2013
3025ZIOP correction... price to cash is more like 4X. With a tip of the hat and thpgo-neil13/26/2013
3024ZIOP down 60% on Pali Ph3 failure. Company trimming to focus on synthetic biolopgo-neil-3/26/2013
3023GENT almost back to even and this: Subject 56721IRWIN JAMES FRANKEL-3/22/2013
3022GENT off 16% premarket on the same news released 2/22 - that the EU against apprIRWIN JAMES FRANKEL-3/22/2013
3021Affymax In Trouble Off another 64% to $1.05 today.Ian@SI-3/19/2013
3020UK minnow Ark Therapeutics 55% - and a genuine firesale: London, UK, 15March 20nigel bates-3/15/2013
3019Spectrum (SPPI) off 36% on drastically -- ~40% -- reduced revenue guidance. Chetuck-3/13/2013
3018Sorry, Harold, but can we take any extended Sangamo discussion to the thread whenigel bates-3/8/2013
3017Is your criticism that SGMO appears to be over promising and that you do not belHarold Engstrom-3/7/2013
3016Affymax (AFFY), which got its drug approved has been forced to do a recall due ttuck-2/25/2013
3015GENT 30-odd %: VILLA GUARDIA, Italy, Feb. 21, 2013 (GLOBE NEWSWIRE) -- Gentium nigel bates-2/21/2013
3014Amicus (FOLD) off ~26% after presenting additional data from this trial, along wtuck-2/15/2013
3013A good biotech stock has something for everybody! :-)The Dodgy Ticker-2/13/2013
3012Peregrine (PPHM) off 20% or so on P2 failure in pancreatic cancer (Bavi + Gemzartuck-2/13/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News